Effects of perioperative oxygen concentration on oxidative stress in adult surgical patients: a systematic review by Oldman, AH et al.
Manuscript Draft. Oldman AH, Cumpstey A. Perioperative Oxidative Stress systematic review. 2020. 
 1 
Title: 
The effects of perioperative oxygen concentration on oxidative stress in adult surgical 
patients: a systematic review  
 
Authors 




1. Critical Care Research Group, Southampton National Institute of Health Research, Biomedical 
Research Centre, University Hospital Southampton, Southampton, SO16 6YD, UK. 
2. Integrative Physiology and Critical Illness Group, Clinical and Experimental Sciences, Faculty of 
Medicine, University of Southampton, Southampton, SO16 6YD, UK.  
3. University of Plymouth, Peninsular Medical School, The John Bull Building, Research Way, 
Plymouth Science Park, Plymouth, PL6 8BU, UK 
4. Intensive Care Unit, Royal Free Hospital, Pond Street, London, NW3 2QG, UK 
5. Department of Anesthesiology, Duke University School of Medicine, Durham, NC, USA 
 





Corresponding author’s address:  
Dr Andrew Cumpstey       
Anaesthesia and Critical Care research group 
Department of Anaesthesia, E Level 





Tel. no.   023 8120 5308  
E-mail address:   a.cumpstey@soton.ac.uk   
Manuscript Draft. Oldman AH, Cumpstey A. Perioperative Oxidative Stress systematic review. 2020. 
 2 
Abstract: 
The fraction of inspired oxygen (FIO2) administered during general anaesthesia varies widely 
despite international recommendations to administer FIO2=0.8 to all anaesthetised patients 
to reduce surgical site infections (SSIs). Anaesthetists remain concerned that high FIO2 
administration intraoperatively may increase harm, through increased oxidative damage and 
inflammation, resulting in more complications and worse outcomes. In previous systematic 
reviews associations between FIO2 and SSIs have been inconsistent, but none have previously 
examined whether lower FIO2 administration reduces perioperative oxidative stress. 
 
Methods  
EMBASE, MEDLINE, and Cochrane databases were searched from inception to 9th March 2020 
for randomised controlled trials (RCTs) comparing higher with lower perioperative FIO2 and 
quantifying oxidative stress in adults undergoing non-cardiac surgery. Candidate studies were 
independently screened by two reviewers and references hand-searched. Methodological 
quality was assessed using the Cochrane Collaboration Risk of Bias tool. 
 
Results  
From 19,438 initial results, seven trials (n=422) were included. Four studies reported markers 
of oxidative stress during caesarean section (n=328) and three reported oxidative stress 
during elective colon surgery (n=94). Risk of bias was low (4 studies) to moderate (3 studies). 
Pooled results suggested high FIO2 was associated with greater malondialdehyde, protein-
carbonyl concentrations and reduced xanthine oxidase concentrations, together with 
reduced antioxidant markers such as superoxide dismutase and total sulfhydryl levels 
although total antioxidant status was unchanged. 




Higher FIO2 may be associated with elevated oxidative stress during surgery. However, limited 
studies have specifically reported biomarkers of oxidation. Given the current clinical 
controversy concerning perioperative oxygen therapy, further research is urgently needed in 
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Introduction 
In 2016, the World Health Organization (WHO) recommended administering a fractional 
inspired oxygen concentration (FIO2) of 0.8 to all intubated patients undergoing surgery to 
reduce surgical site infections (SSIs).1 2 This was based on a meta-analysis of 15 trials 
performed by the WHO guideline development group (GDG),3 and remains controversial 
amongst anaesthetists.4–6 Notably, the findings of the largest trial available at the time (the 
PROXI study, n=1378,7) were deemed ‘biologically implausible’ by the GDG for reasons that 
remain obscure.2 Post-hoc analyses from PROXI suggested higher intraoperative FIO2 could 
be associated with higher long-term mortality in patients with cardiac disease and/or cancer.8 
9 A better understanding of the mechanisms underlying such outcome differences is essential 
to resolve this debate. 
Systemic detrimental effects of oxygen are often thought to be mediated through ‘oxidative 
stress’ - an imbalance between the production of highly reactive by-products of metabolism 
(reactive oxygen species, ROS) and endogenous antioxidant defence mechanisms, also 
affecting local and systemic redox status.10–12 ROS are largely formed during mitochondrial 
oxidative phosphorylation, or within neutrophil/macrophages and non-phagocytic cells.13–15 
ROS can irreversibly damage lipids, proteins and DNA; triggering cell death through apoptosis 
or necrosis.13 14 Oxidative stress can be beneficial (e.g. in phagocytosis) but can also lead to 
tissue damage and organ failure.16 17 
Direct detection of ROS remains challenging due to their short half-life. Markers of oxidation 
and antioxidant status are therefore used as indirect measures of ROS activity. Common 
markers of oxidation include lipid peroxides (e.g. malondialdehyde (MDA), F2-isoprostanes 
and organic hydroperoxides (OHP)), which indicate levels of cellular lipid oxidation.18 19 
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Similarly, protein carbonyl moieties (PCO) reflect levels of cellular protein oxidation.20 
Xanthine oxidase (XO), a ROS generating enzyme, has also been used to assess 
ischaemic/reperfusion injury perioperatively; with tissue damage thought to be mediated by 
ADP catabolism, acidosis, subsequent XO production and neutrophil mediation.21–23 
Well-studied antioxidant enzymes include superoxide dismutase (SOD), glutathione 
peroxidase and catalase. Thiols (protein or non-protein compounds with free sulfhydryl 
groups) are also major targets of ROS-induced oxidation and common markers of extracellular 
(e.g. plasma) redox status, whilst the reduced to oxidized glutathione (GSG/GSSG) ratio is a 
common intracellular marker.24 Total antioxidant status (TAS) is a popular colorimetric assay 
used to compare overall levels of ‘antioxidant reserve capacity’ across different clinical 
samples.25 26 
Oxidative stress, fundamental to the inflammatory surgical stress response,16 27 28 is 
associated with more post-operative complications and worse post-operative outcomes.28–31 
However, whether administering lower FIO2s intraoperatively reduces the magnitude of 
perioperative oxidative stress has not previously been determined.  
 
Methods 
This review is reported in accordance with the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA),32 and was prospectively registered online at 
International Prospective Register of Systematic Reviews (PROSPERO, ID: CRD42017078995).  
Selection criteria 
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Randomised controlled trials (RCTs), published in English, in adult (aged 18 years or more) 
patients undergoing any non-cardiac procedure in an operating theatre under general 
anaesthesia and not requiring one lung ventilation, neurosurgery or hyperbaric oxygen 
therapy were eligible. All included studies reported biochemical levels of oxidative stress (as 
agreed by all authors) in response to administration of either a high or low intraoperative FIO2 
(>0.6 vs <0.4, or ≥ 20% difference between interventional groups).  
Search Strategy 
EMBASE, MEDLINE, and Cochrane databases were searched from inception until 9th March 
2020 for keywords relating to ROS, oxidative stress, oxygen, hyperoxia, anaesthesia and 
surgery. Full search strategies are detailed in Appendix A. Two authors (AHO & AFC) 
independently identified potentially eligible studies by screening all titles and abstracts using 
Rayyan (systematic review web application,33). Any disagreements were resolved by 
discussion with all other authors. Full texts of potentially eligible studies were obtained and 
reviewed by two authors (AHO & AFC). Review by other authors was available if consensus 
could not be reached, but not necessary. Included articles’ references were then hand-
searched for completeness.  
Data Extraction & assessment of methodological quality 
Data was extracted, placed in an analysis table and independently cross checked by two 
authors (AHO & AFC). One author (AHO) used the Cochrane Collaboration Tool to assess Risk 
of Bias (CCRB) to assess methodological quality. Studies were scored as high, low or unclear 
risk in each of the following domains: random sequence generation, allocation concealment, 
blinding of participants and personnel, blinding of outcome assessment, complete outcome 
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data, selective reporting and other biases. Due to the high level of heterogeneity in the small 
number of results, a meta-analysis was not performed. 
 
Results 
The initial search located 19,438 results, of which 984 were duplicates. 124 were deemed 
potentially eligible following title and abstract review but 116 were excluded on reviewing 
the full texts, leaving 8 eligible studies (see figure 1). The most common reasons for exclusion 
were only reporting clinical outcomes and not specifically reporting on biochemical measures. 
One article was subsequently excluded from the analysis due to missing data despite attempts 
to contact the authors.34 Data from 422 patients in 7 studies were included in the final 
analysis.  
Characteristics of included studies 
From the available data, mean age was 38 (SD 13.9) years and weight 66.9 (SD 3.1) Kg. Of the 
6 trials reporting participants’ sex (n = 392 total), only 47 (12%) participants were male. All 7 
RCTs included in the analysis reported different biomarkers of oxidative stress in surgical 
patients (see table 1).35–41 Four studies (three of which were from the same group) reported 
oxidative stress in maternal and fetal blood samples collected during either elective or 
emergency caesarean section.37–39 41 One trial reported markers of oxidative stress in serum 
and bronchoalveolar lavage samples collected from 40 patients undergoing a hemicolectomy 
procedure under general anaesthesia,40 and the final two studies (both from the same group) 
studied both mucosal and arterial levels of MDA intraoperatively and postoperatively during 
colon surgery.35 36 
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Risk of bias in included studies 
Of the seven studies analysed, four were deemed to have low risk of bias across all 
domains,38–41 and three articles were deemed to have a moderate risk of bias due to no 
reporting on blinding and patient group allocation concealment.35–37 A risk bias summary grid 
depicting these results in shown in figure 2. Combined results are listed in tables 1 and 2.    
Markers of Oxidation 
MDA was the most commonly reported biomarker of oxidative stress, reported in 5 of the 7 
studies.35–37 40 41 Two studies demonstrated significant increases in MDA with higher FIO2 in 
maternal & umbilical serum,37 and bronchial lavage.40 Two other studies (from the same 
group) reported significantly lower mucosal and postoperative arterial MDA concentrations 
with an FIO2 of 0.8,35 36 and neither maternal nor umbilical MDA concentrations changed in 
the remaining study.41 
Three separate studies (from the same group) reported maternal and umbilical isoprostane 
concentrations.37–39 Although the earliest of these reported significant increases in the higher 
FIO2 (=0.6) group,37 no significant differences were demonstrated in the latter two studies.38 
39   
High FIO2 was also associated with higher fetal organic hydroperoxide (OHP) concentrations,37 
lower bronchial PCO concentrations40 and lower mucosal XO concentrations36 in three 
separate studies.  
Antioxidant and cellular redox status 
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No differences in oxidised and reduced glutathione were demonstrated, either 
intraoperatively (1 hour after induction) or 6 hours after surgery, in two separate studies 
(both FIO2 0.3 vs 0.8) from the same group.35 36  
Only two RCTs reported on other markers of antioxidant status (see Table 2). Koksal et al. 
reported significant decreases in arterial and BAL SOD and PSH, and also BAL NPSH, with lower 
FIO2 (0.4 vs 0.8) in 40 patients having colorectal surgery,40 and Ahuja et al. reported no 
changes in TAS between control (FIO2 0.21) and intervention (FIO2 0.5) and in either maternal 




Evidence from this systematic review suggests that higher intraoperative FIO2 could be 
associated with increased perioperative oxidative stress. Evidence from 138 patients across 
four studies demonstrated increased biomarkers of oxidative stress in serum and alveolar 
samples collected from patients receiving high FIO2.35–37 40 However, the number and size of 
all of these studies was small and considerable uncertainty remains about which redox 
pathways might be most affected by intraoperative oxygen administration. We believe this to 
be the first systematic review reporting oxidative stress in response to different FIO2s during 
surgery, and our findings show few (exclusively small single-centre) trials have explored this 
during surgery to date. This is surprising given that in many other clinical settings adverse 
outcomes have been associated with both excess oxygen administration,42–50 and also 
different markers of redox activity.51–60  
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Significant increases in MDA (used as a serum and tissue marker in 4 of the 7 included trials) 
were observed across neonatal cord blood, arterial, bronchial and colon mucosal samples 
given high FIO2. MDA and isoprostane represent final oxidation products of polyunsaturated 
fatty acids, suggesting FIO2 might affect lipid membrane composition during surgery. 
Interestingly, serum MDA concentrations showed no change between different FIO2 levels 
(0.4 and 0.8) in one study, but did increase within BAL and arterial samples, suggesting most 
oxidative stress may occur within the pulmonary vasculature.40 ROS induced hyperoxia 
induced acute lung injury (HALI), a state of increased permeability of the alveolar/vascular 
interface and endothelial disruption (also mediated by interleukins, cytokines and 
chemokines) is well described,61 and direct disruption of type 2 epithelial cells by oxidative 
and inflammatory mediators promotes cellular apoptotic and necrotic pathways.62  
In contrast during elective C-section, isoprostane and MDA concentrations in both maternal 
and umbilical serum increased up to 2-fold with FIO2 0.6,37 supporting other research showing 
that redox mediators can cross the placenta.63 However, MDA concentrations did not change 
in a second study where mothers received FIO2 of 0.21 or 0.5 during both elective and 
emergency operations,41 possibly due to either the lower FIO2 or shorter duration (<10 
minutes vs >52 minutes) of oxygen exposure. Oxidative stress has been implicated in multiple 
obstetric complications including preterm labour, maternal vascular disease and miscarriage, 
with ROS formation causing lipid peroxidation, membrane disruption of placental tissue, and 
dysregulation of fetal growth and development.64–66 It is worth noting that all participants in 
Khaw et al.’s trials received spinal (regional) anaesthesia alone, so these results may not be 
directly comparable to patients undergoing endotracheal intubation and general anaesthesia.  
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Only one trial reported xanthine oxidase (XO) expression, an enzyme family known to directly 
generate ROS,36 suggesting that inspiring high FIO2 may attenuate XO activity at a tissue level 
and reduce ROS production. Given that urate, a common product of XO activity, is also one of 
the main constituents of many assays used to measure total antioxidant capacity,67 other 
measures of antioxidant activity might also be expected to respond similarly to hyperoxia. 
Lack of consistency as to how antioxidant status is reported makes direct comparison 
challenging - two studies only reported oxidised and reduced glutathione concentrations,35 36 
whilst two other trials reported alternative markers of activity including SOD, NPSH, PSH and 
TAS.40 41 In one of these latter trials, SOD expression and both NPSH and PSH concentrations 
were significantly reduced with high FIO2 administration,40 suggesting that lower 
concentrations of oxygen may stimulate a greater antioxidant response or that excess oxygen 
might ‘consume’ cellular antioxidant capacity. In contrast, the other trial reported no 
significant differences in TAS,41 suggesting oxidative stress was not associated with reciprocal 
anti-oxidation responses in these procedures performed under regional (as opposed to 
general) anaesthesia. 
Our analysis is limited by the quantity and quality of research conducted in this area. Of the 
seven studies identified in the current systematic review, only four studies were deemed to 
have low risk of reporting bias in all domains (figure 3). Furthermore, a high proportion of 
participants were young females as four of the seven included studies (more than half of all 
of the included trials) only recruited participants having Caesarean section procedures. It is 
not known how perioperative redox changes might differ between obstetric and non-
obstetric surgery, but redox markers are known to vary with age, sex, body habitus and 
pregnancy.68 Another limitation that has hampered progress in this field is the lack of a 
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conceptual framework for what oxidative stress actually means in vivo. Many different 
readouts have been proposed and are currently being used as indicators of the involvement 
of ROS in clinical settings without a clear understanding what any of these analytes actually 
‘mark’ or how these different ‘readouts of cellular activity’ may interact with each other.69  
Taken together, our findings evidence a striking lack of high-quality research exploring the 
cellular consequences of perioperative oxygen administration in patients undergoing major 
surgery. Historically, perioperative oxygen research has focussed on the effects of hyperoxia 
on SSI rates as well as nausea and vomiting.70–72 However, larger trials (such as PROXI) and 
meta-analyses demonstrate that the presumed association between hyper-oxygenation and 
reduction in SSI rates is uncertain,7 73 and there remains strong evidence to suggest that ROS 
formation increases perioperative tissue inflammation.68 Understanding whether oxygen 
causes shifts in the production of ROS and antioxidants has considerable clinical implications 
and more work is urgently needed to explore these mechanisms that underlie so many 
current practices in perioperative medicine. 
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19,438 initial results 
MEDLINE, EMBASE, Cochrane  
18,454 titles and abstracts read 
124 full texts accessed 
984 duplicates excluded 
18,330 excluded through initial title and 
abstract screening 
116 excluded through full text review: 
 
Only clinical outcomes reported (no markers 
of redox activity): 
Surgical Site infection (n=30) 
Inflammation (n=2) 
Pulmonary function (n=30) 
Post-op nausea and vomiting (n=16) 
Maternal and fetal physiology (n=23) 
Cardiac function (n=8) 
Surgical complications (n=3) 
Cerebral blood flow (n=2) 
Haematological counts (n=2) 
8 RCTs included for 
methodological quality assessment  
 
Excluded due to lack of data (n=1)  
 
 
7 RCTs fully analysed (patient n=422) 
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Tables 
Table 1. Combined results of RCTs reporting on markers of oxidative stress in arterial blood, fetal blood, and bronchial lavage samples. *p<0.05 **p<0.01. EL C/S elective 














Xanthine Oxidase, XO  
 
Khaw et al. 
2002 















0.18 vs 0.39** 0.4 vs. 0.4** - - 
Khaw et al. 
2009 
125 0.21 vs. 0.6 
Maternal venous 
(pg ml-1) 
225 vs. 240.7  - - - - 
Umbilical venous  
(pg ml-1) 
427 vs. 471  - - - - 
Umbilical arterial  
(pg ml-1) 
457 vs. 473 - - - - 
Khaw et al. 
2010 
39 
0.3 vs. 0.5  
vs. 1.0 
Maternal arterial  
(pg ml-1) 
154 vs. 156  
vs. 158  
- - - - 
Umbilical venous  
(pg ml-1) 
480 vs. 416  
vs. 441  
- - - - 
Umbilical arterial  
(pg ml-1) 
410 vs. 368  
vs. 468  
- - - - 
 






0.4 vs. 0.8 
Subject arterial  
(nmol mg-1) 




- - 7.7 vs. 12.6** 10.1 vs. 4.5** - 









- - 6.1 vs. 6.2 - - 
Umbilical venous 
(µM) 
- - 5.3 vs. 4.8 - - 
Umbilical arterial 
(µM) 
- - 5.4 vs. 4.3 - - 
0.21 vs. 0.5 
Maternal arterial 
(µM) 
- - 6.1 vs. 6.2 - - 







- - 5.1 vs. 5.5 - - 
Umbilical venous 
(µM) 
- - 5.4 vs. 4.8 - - 
Garcia de la 
Asuncion et 
al. 2007 
30 0.3 vs 0.8 
Subject arterial 1 
hour after induction 
 (nmol ml-1) 
- - 0.6 vs. 0.5 - - 
Subject arterial 6 
hours post-op 
(nmol ml-1) 
- - 0.65 vs. 0.4* - - 
Garcia de la 
Asuncion et 
al. 2013 
24 0.3 vs. 0.8 
Subject mucosal 
(nmol mg-1 protein-1) 
- - 2.0 vs. 1.0**  - - 
Subject mucosal 
(mU mg-1 protein-1) 
- - - - 595 vs. 310* 
Subject arterial 
(nmol mg-1 ml-1) 
- - 1.5 vs. 0.4**  - - 
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SOD (nmol mg-1) 
Non-protein sulfhydryl, 
NPSH (nmol mg-1) 
Protein sulfhydryl, 
PSH (nmol mg-1) 
Reduced Glutathione, 
GSH (µmol ml-1) 
Oxidised 
Glutathione, GSSG 
(nmol mg-1 ml-1) 
Total Antioxidant 





40 0.4 vs. 0.8 











30 0.3 vs 0.8 
Subject arterial 
1 hour after 
induction 
- - - 0.68 vs 0.58 20 vs 30  
Subject atrial 6 
hours post-op 







24 0.3 vs. 0.8 
Subject arterial 
 











0.21 vs 0.5 
Maternal 
arterial 
- - - - - 1.1 vs. 1.1 
Umbilical 
arterial 
- - - - - 1.2 vs. 1.3 
Umbilical 
venous 
- - - - - 






0.21 vs 0.5 
Umbilical 
arterial 
- - - - - 1.1 vs. 1.1 
Umbilical 
venous 
- - - - - 1.6 vs. 1.5 
 
 
 
 
